- Home
- U vs CORT Comparison
U vs CORT Comparison
Compare U & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | CORT |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0B | 7.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | U | CORT |
|---|---|---|
| Price | $43.88 | $82.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | $39.84 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 8.0M | 821.3K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $1,803,658,000.00 | $741,172,000.00 |
| Revenue This Year | $3.13 | $23.79 |
| Revenue Next Year | $12.89 | $40.97 |
| P/E Ratio | ★ N/A | $92.87 |
| Revenue Growth | N/A | ★ 17.92 |
| 52 Week Low | $15.33 | $49.00 |
| 52 Week High | $52.15 | $117.33 |
Technical Indicators
Market Signals| Indicator | U | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 51.39 | 51.62 |
| Support Level | $43.65 | $78.07 |
| Resistance Level | $52.15 | $89.00 |
| Average True Range (ATR) | 2.19 | 3.40 |
| MACD | -0.28 | -0.11 |
| Stochastic Oscillator | 25.18 | 39.42 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.